Rapid and Dynamic Quantitative Screening of Synthetic Cannabinoids with DART-MS Analysis: A Collaborative Case Study

Discover Our Rapid Screening of Synthetic Cannabinoids

Start your learning journey with an insightful presentation on a novel rapid and quantitative screening approach for detecting and measuring 16 synthetic cannabinoids using DART-MS by Lauren Ritter, Alex Maggitti and Terry Bates.

Why Watch This Webinar? 

Discover how our innovative approach addresses the drawbacks of traditional immunoassay-based detection, such as cross-reactivity and low sensitivity. Learn about the high selectivity and accuracy of the DART-MS screening method, validated through comparative studies with LC-MS using confirmed positive urine samples. With a throughput of under 30 seconds per sample, this method offers a cost-effective and efficient solution for detecting synthetic cannabinoids in urine samples.

Key Takeaways:

• Innovative Screening Approach: Understand the benefits of using DART-MS for rapid and quantitative detection of synthetic cannabinoids.
• High Selectivity and Accuracy: Learn about the method's validation through comparative studies with LC-MS.
• Efficiency and Cost-Effectiveness: Discover how this approach can streamline your workflow with a throughput of under 30 seconds per sample.

Don't miss this opportunity to enhance your knowledge and skills in synthetic cannabinoid detection. Register now to watch the on-demand webinar and take your analytical capabilities to the next level!

Rapid and Dynamic Quantitative Screening of Synthetic Cannabinoids with DART-MS Analysis: A Collaborative Case Study